Attention: You are using an outdated browser, device or you do not have the latest version of JavaScript downloaded and so this website may not work as expected. Please download the latest software or switch device to avoid further issues.

News > Research buzz > Third COVID-19 vaccine dose effectively boosts immunity for the majority of patients with cancer

Third COVID-19 vaccine dose effectively boosts immunity for the majority of patients with cancer

Nearly 100% of cancer patients with solid tumours have antibodies effective against the Delta variant after a third dose of COVID-19 vaccine, according to new results published in Cancer Cell.
23 Dec 2021
United Kingdom
Research buzz

To view this News Article please log in or create a profile

Similar stories

Scientists at the Crick have found a new treatment target for CDKL5 deficiency disorder (CDD), one of the most common types of genetic epilepsy. More...

Left: embryonic mouse heart with defects. Right: heart with Dyrk1a restored to normal levels

Researchers at the Crick and UCL have identified a gene that causes heart defects in Down syndrome, a condition that res… More...

The medieval cemetery where an individual with Klinefelter syndrome was found (Oxford Archaeology)

Crick researchers, working with University of Oxford, University of York and Oxford Archaeology, have developed a new te… More...

A type of immune cell can help predict which patients may benefit most from cancer immunotherapies researchers from the … More...

Researchers at the Crick & UCL Queen Square Institute of Neurology have shown that an increase in a type of tau protein … More...

Have your say

 
image

Contact us

The Francis Crick Institute
1 Midland Road
London
NW1 1AT

connect@crick.ac.uk


This website is powered by
ToucanTech